Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens

Establishing a cancer screening biomarker’s intended performance requires “phase III” specimens obtained in asymptomatic individuals before clinical diagnosis rather than “phase II” specimens obtained from symptomatic individuals at diagnosis. We used specimens from the Prostate, Lung, Colorectal, a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Cramer, Daniel W., Bast, Robert C., Berg, Christine D., Diamandis, Eleftherios P., Godwin, Andrew K., Hartge, Patricia, Lokshin, Anna E., Lu, Karen H., McIntosh, Martin W., Mor, Gil, Patriotis, Christos, Pinsky, Paul F., Thornquist, Mark D., Scholler, Nathalie, Skates, Steven J., Sluss, Patrick M., Srivastava, Sudhir, Ward, David C., Zhang, Zhen, Zhu, Claire S., Urban, Nicole
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3085251/
https://ncbi.nlm.nih.gov/pubmed/21372036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-10-0195
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires